Bronchiolitis Obliterans SyndromeRisk Factors and Therapeutic Strategies

被引:0
作者
Andrew I. R. Scott
Linda D. Sharples
Susan Stewart
机构
[1] Papworth Hospital NHS Trust,Transplant Unit
[2] University Forvie Site,MRC Biostatistics Unit
来源
Drugs | 2005年 / 65卷
关键词
Tacrolimus; Acute Rejection; Fluticasone Propionate; Daclizumab; Obliterative Bronchiolitis;
D O I
暂无
中图分类号
学科分类号
摘要
Post-transplantation bronchiolitis obliterans syndrome (BOS) is a clinicopathological syndrome characterised histologically by obliterative bronchiolitis (OB) and physiologically by airflow limitation. It affects long-term survival with no consistently effective treatment strategy.
引用
收藏
页码:761 / 771
页数:10
相关论文
共 246 条
[1]  
Burke CM(1984)Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation Chest 86 824-9
[2]  
Theodore J(1999)Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 828-37
[3]  
Dawkins KD(2002)Risk factors for bronchiolitis obliterans: a systematic review of recent publications J Heart Lung Transplant 21 271-81
[4]  
El-Gamel A(1993)A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts International Society for Heart and Lung Transplantation. J Heart Lung Transplant 12 713-6
[5]  
Sim E(2002)Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 297-310
[6]  
Hasleton P(2000)Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life Am J Respir Crit Care Med 161 1937-41
[7]  
Sharpies LD(2000)Bronchiolitis obliterans syndrome and additional costs of lung transplantation Chest 118 1648-52
[8]  
McNeil K(1995)Bronchiolitis obliterans in recipients of single, double and heart-lung transplantation Chest 107 973-80
[9]  
Stewart S(1998)Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors J Heart Lung Transplant 17 1255-63
[10]  
Cooper JD(1996)Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group J Heart Lung Transplant 15 1-15